Azole resistance in Aspergillus species: Promising therapeutic options

Author(s):  
Shirisha Pasula ◽  
Pranatharthi H. Chandrasekar
Author(s):  
Stephanie J. Smith ◽  
Rohini J. Manuel ◽  
Christopher C. Kibbler

There are more than 200 Aspergillus species, with over 30 known to be human pathogens. The fungus is also commercially important. Aspergillus niger is the source of enzymes such as amylases, lipases, and proteases and is used to produce the majority of the world’s citric acid. Diseases caused by Aspergillus species can vary widely, from superficial colonization to invasive and allergic disease. Mortality from invasive disease remains high, despite an increase in the number of antifungals available for therapy. Azole resistance is increasing, especially in Europe, and appears to be related to the use of azoles for agriculture.


Author(s):  
Silvio Ragozzino ◽  
Daniel Goldenberger ◽  
Patrick R Wright ◽  
Stefan Zimmerli ◽  
Konrad Mühlethaler ◽  
...  

Abstract Among 400 Aspergillus spp. from respiratory samples in Switzerland, A. fumigatus was the most frequent species. Non-fumigatus Aspergillus spp. were more prevalent among solid-organ transplant recipients and after azole exposure. Azole-resistance was detected in four A. fumigatus isolates, three of them with the “environmental” mutation TR34/L98H in the cyp51A gene.


2020 ◽  
Vol Volume 13 ◽  
pp. 4663-4672
Author(s):  
Yuan Xu ◽  
Min Chen ◽  
Junhao Zhu ◽  
Bert Gerrits van den Ende ◽  
Amanda Juan Chen ◽  
...  

2021 ◽  
Vol 8 (Supplement_1) ◽  
pp. S561-S562
Author(s):  
Nicholas A Marschalk ◽  
Palash Samanta ◽  
Eun Jeong Kwak ◽  
Minh-Hong Nguyen

Abstract Background Invasive aspergillosis (IA) causes significant morbidity and mortality in lung transplant (LTx) recipients. Antifungal resistance in Aspergillus species is on the rise globally with specific concern in Europe related to the TR34/L98H mutation in the cyp51A enzyme that induces pan-azole resistance. Azole exposure is a known risk factor for development of resistant Aspergillus, but this is less well described in LTx population. Methods We reviewed the electronic medical records of LTx patients with respiratory cultures positive for Aspergillus species known to be inherently resistant or any Aspergillus species tested to be resistant to one or more triazole from 2010 to 2019. For available isolates, Sanger sequencing was performed on cyp51A with primers targeting the promoter region and 3 known hotspot areas. Results Twenty eight patients met inclusion criteria and 2.7% (28/1026) Aspergillus isolates were azole-resistant during study period (Figure 1). Median time from LTx to resistant Aspergillus growth was 196 days (range 14 - 3146). There was a cluster of positive cultures within 1-year post-Tx period (13/28). Azole exposure varied, from 7 to 2443 days (median 128). There was no change in incidence over the study period. The most common species was Aspergillus calidoustus (Figure 2). Twenty cases were deemed colonization, vs 5 probable IFI and 3 proven IFI. Mortality of IFI with resistant Aspergillus was 38% (3/8), higher than azole-susceptible IA (p=0.05). Twelve isolates were available for sequencing; none carried TR34/L98H mutation. There was wide variation in mutations, ranging from 1 to 12 point mutations in the cyp51 enzyme, many of them SNPs previously described as engendering an azole resistant phenotype (Figure 3). Aspergillosis-free Survival by Resistant and Susceptible Isolates Development of azole-resistant aspergillus colonization/infection was rare relative to common occurrence of colonization/infection with susceptible isolates in the lung transplant recipient population Azole Resistant Aspergillus Species Isolated from Lung Transplant Recipients The most commonly isolated species were A. calidoustus and ustus. Only 4/28 isolates were A. fumigatus. Azole Resistant Aspergillus Genotypic Analysis Sequenced isolates showed wide variability in point mutations. M220V, G54, and G448 were the only mutations observed more than once. 3 isolates were wild type. Conclusion Azole resistant Aspergillus infections remain an uncommon problem in LTx. The majority of isolates were deemed colonization, but mortality was high when IFI was present. Most isolates had mutations within the hot spot regions of cyp51A known to induce azole resistance. There were no TR34/L98H mutants found in our patient population. Disclosures Minh-Hong Nguyen, MD, Merck (Grant/Research Support)


2019 ◽  
Vol 57 (8) ◽  
pp. 997-1003 ◽  
Author(s):  
Yasuhiro Tsuchido ◽  
Michio Tanaka ◽  
Satoshi Nakano ◽  
Masaki Yamamoto ◽  
Yasufumi Matsumura ◽  
...  

Abstract The prevalence of azole-resistant Aspergillus fumigatus (ARAF) in Japan is unclear. We aimed to investigate the epidemiology of clinically isolated Aspergillus species and the frequency of azole resistance in Aspergillus species, particularly Aspergillus fumigatus, in the Kyoto and Shiga regions of Japan. Strains of clinically isolated Aspergillus species were prospectively collected from nine acute care hospitals. Species identification was performed by DNA sequence analysis, and all strains were subjected to antifungal susceptibility testing. Sequencing of the Aspergillus cyp51A gene and promoter region and genotyping by short tandem repeats were performed for ARAF isolates. A total of 149 strains were collected, and 130 strains were included for the subsequent analysis after the exclusion of duplicate isolates. The most commonly isolated species was Aspergillus fumigatus, accounting for 43.1% (56 isolates) overall, and seven (12.7%) of 55 strains of A. fumigatus were azole-resistant. Azole-resistance of other Aspergillus species were also found that two (22.2%) of nine strains of A. tubingensis and two (28.6%) of seven strains of A. flavus were azole-resistant. DNA sequence analysis of the ARAF strains revealed that two carried the cyp51A TR34/L98H mutation, one carried G448S, one carried M220I, and three had no relevant mutations (wild type). Genotyping and phylogenetic analyses showed that the TR34/L98H strains were clustered with the strains from the Netherlands and France. These data suggest the emergence of ARAF with TR34/L98H in Japan, and continuous surveillance will be important to identify trends in resistance.


2020 ◽  
Vol 6 (4) ◽  
pp. 315
Author(s):  
Irene Gonzalez-Jimenez ◽  
Jose Lucio ◽  
Jorge Amich ◽  
Isabel Cuesta ◽  
Rafael Sanchez Arroyo ◽  
...  

The emergence and spread of Aspergillus fumigatus azole resistance has been acknowledged worldwide. The main problem of azole resistance is the limited therapeutic options for patients suffering aspergillosis. Azole resistance mechanisms have been mostly linked to the enzyme Cyp51A, a target of azole drugs, with a wide variety of modifications responsible for the different resistance mechanisms described to date. However, there are increasing reports of A. fumigatus strains showing azole resistance without Cyp51A modifications, and thus, novel resistance mechanisms are being explored. Here, we characterized two isogenic A. fumigatus clinical strains isolated two years apart from the same patient. Both strains were resistant to clinical azoles but showed different azole resistance mechanisms. One strain (CM8940) harbored a previously described G54A mutation in Cyp51A while the other strain (CM9640) had a novel G457S mutation in Cyp51B, the other target of azoles. In addition, this second strain had a F390L mutation in Hmg1. CM9640 showed higher levels of gene expression of cyp51A, cyp51B and hmg1 than the CM8940 strain. The role of the novel mutation found in Cyp51B together with the contribution of a mutation in Hmg1 in azole resistance is discussed.


Mycoses ◽  
2019 ◽  
Vol 62 (12) ◽  
pp. 1174-1181 ◽  
Author(s):  
Yi‐Chun Chen ◽  
Shu‐Fang Kuo ◽  
Hsuan‐Chen Wang ◽  
Chi‐Jung Wu ◽  
Yin‐Shiou Lin ◽  
...  

2011 ◽  
Vol 49 (6) ◽  
pp. 2243-2251 ◽  
Author(s):  
Klaus Leth Mortensen ◽  
Rasmus Hare Jensen ◽  
Helle Krogh Johansen ◽  
Marianne Skov ◽  
Tacjana Pressler ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document